Bullish MAXCP Stocks
9/15/2014
Avanir Pharmaceuticals (AVNR) soared 85.3% to 12.49 after reporting positive clinical trial results for its drug that treats behavioral and psychiatric symptoms of patients with Alzheimer's disease.